UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adverse cutaneous drug eruptions: current understanding

Seminars in immunopathology, 2016-01, Vol.38 (1), p.75-86

2016

Volltextzugriff (PDF)

A-293 Erythrodermic Folliculotropic Mycosis Fungoïdes successfully treated with Bexaroten plus nbUVB and chlormethine gel

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab

Current problems in dermatology, 2018, Vol.53, p.70

2018

Volltextzugriff (PDF)

446 IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S257-S257

2022

Volltextzugriff (PDF)

A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

A-283 Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

A-116 Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

A-153 Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

A-294 Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospectivemulticentre study [PUBLISHED ARTICLE]

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

264 Increased chlormethine induced DNA double stranded breaks in malignant T cells from mycosis fungoides skin lesions

Journal of investigative dermatology, 2021-10, Vol.141 (10), p.S194-S194

2021

Volltextzugriff (PDF)

1572 HLA I shields tumor lymphocytes from NK-cell-mediated elimination in the skin

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S270-S270

2023

Volltextzugriff (PDF)

A-267 Skin-Limited Versus Extended Manifestation In BPDCN Patients: A Retrospective Multi-Centre Observational Study

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

439 Cytometry and machine learning based approaches for diagnosis of malignant cells in Sézary syndrome

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S256-S256

2022

Volltextzugriff (PDF)

Incidental Finding of Lamellar Calcification of the Falx Cerebri Leading to the Diagnosis of Gorlin-Goltz Syndrome

Case reports in dermatology, 2013-10, Vol.5 (3), p.301-303

2013

Volltextzugriff (PDF)

020 Cytokine imbalance during targeted therapies for psoriasis and atopic dermatitis – the yin yang of Th17 and Th2

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S184-S184

2022

Volltextzugriff (PDF)

086 Terbinafine-resistant dermatophytosis: an emerging global health threat

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S195-S195

2022

Volltextzugriff (PDF)

Histiocytoid Sweet’s Syndrome in a patient with myelodysplastic syndrome with multilineage dysplasia (MDS-MLD), and monoclonal gammopathy of undetermined significance (MGUS) IgG kappa type

European journal of cancer (1990), 2022-09, Vol.173, p.S12-S13

2022

Volltextzugriff (PDF)

Treatment-refractory bullous pemphigoid in a patient with Sézary syndrome

European journal of cancer (1990), 2022-09, Vol.173, p.S49

2022

Volltextzugriff (PDF)

Exacerbation of mycosis fungoides masquerading as psoriasis under cytokine-pathway blockers

European journal of cancer (1990), 2022-09, Vol.173, p.S48-S49

2022

Volltextzugriff (PDF)

IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma

European journal of cancer (1990), 2022-09, Vol.173, p.S29

2022

Volltextzugriff (PDF)

198 The involvement of immunogenic cell death in extracorporeal photopheresis

Journal of investigative dermatology, 2023-11, Vol.143 (11), p.S365

2023

Volltextzugriff (PDF)

A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

1569 A specific inflammatory gene signature in pityriasis rubra pilaris identifies a pathogenic role for keratinocytes

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S269-S269

2023

Volltextzugriff (PDF)

A-276 Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation triggered by Extracorporeal Photopheresis in CTCL

European journal of cancer (1990), 2024-10, Vol.211

2024

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

ThemaSkin Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(16)

Menü

Weitere Dienste

Einstellungen

Adverse cutaneous drug eruptions: current understanding

A-293 Erythrodermic Folliculotropic Mycosis Fungoïdes successfully treated with Bexaroten plus nbUVB and chlormethine gel

Adverse Reactions of Antibody-Therapy for Primary Cutaneous Lymphomas: Rituximab, Brentuximab Vedotin, Alemtuzumab, and Mogamulizumab

446 IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma

A-154 Potential mogamulizumab-associated inflammatory bowel disease in cutaneous T-cell lymphoma management

A-283 Multi-omics cytokine screening reveals immunosuppressive microenvironment in cutaneous T-cell lymphoma

A-116 Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis

A-120 Radiotherapy of Cutaneous Lymphomas: Real-world Pattern-of-Care Analysis Among EORTC Members

A-153 Primary cutaneous T-cell lymphoma not otherwise specified (NOS) uncovering a novel RAB27A variant in Griscelli syndrome type 2

A-294 Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospectivemulticentre study [PUBLISHED ARTICLE]

264 Increased chlormethine induced DNA double stranded breaks in malignant T cells from mycosis fungoides skin lesions

1572 HLA I shields tumor lymphocytes from NK-cell-mediated elimination in the skin

A-267 Skin-Limited Versus Extended Manifestation In BPDCN Patients: A Retrospective Multi-Centre Observational Study

439 Cytometry and machine learning based approaches for diagnosis of malignant cells in Sézary syndrome

Incidental Finding of Lamellar Calcification of the Falx Cerebri Leading to the Diagnosis of Gorlin-Goltz Syndrome

020 Cytokine imbalance during targeted therapies for psoriasis and atopic dermatitis – the yin yang of Th17 and Th2

086 Terbinafine-resistant dermatophytosis: an emerging global health threat

Histiocytoid Sweet’s Syndrome in a patient with myelodysplastic syndrome with multilineage dysplasia (MDS-MLD), and monoclonal gammopathy of undetermined significance (MGUS) IgG kappa type

Treatment-refractory bullous pemphigoid in a patient with Sézary syndrome

Exacerbation of mycosis fungoides masquerading as psoriasis under cytokine-pathway blockers

IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma

198 The involvement of immunogenic cell death in extracorporeal photopheresis

A-298 RESMAIN: Results of a multicenter, randomized, double blind, placebo-controlled trial to evaluate RESminostat for MAINtenance treatment in advanced stage Mycosis fungoides or Sézary syndrome

1569 A specific inflammatory gene signature in pityriasis rubra pilaris identifies a pathogenic role for keratinocytes

A-276 Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation triggered by Extracorporeal Photopheresis in CTCL

Aktive Filter

Suchergebnisse filtern